Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course Oncology Therapy (SCOT) in Adjuvant Colorectal Cancer
2007-003957-10Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Dec 2007
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of oxaliplatin in colorectal cancer (CRC) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Disease-free survival. Started Dec 2007; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2007-003957-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003957-10.